drugset / Trial / NCT01756521
A Study Study to Investigate the Effect on QT/QTc Interval of Moxifloxacin After a Single Dose in Healthy Male Subjects
Phase 1
Completed
39 enrolled
Seoul National University Hospital
Korea National Enterprise for Clinical Trials · collabSeoul National University Bundang Hospital · collabThe Catholic University of Korea · collab
RandomizedCrossoverOpen-labelDiagnostic
Summary
The purpose of this study is to evaluate effect of moxifloxacin on QT/QTc interval in healthy male subjects. Moxifloxacin is a positive control drug used in QT study. In this study, moxifloxacin 400mg and 800mg will be used, to get information on effect of moxifloxacin on QT/QTc interval.
Timeline
- Start
- 2013-01
- Primary completion
- 2013-08
- Completion
- 2013-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Moxifloxacin | Small molecule | 400 mg | — |
| Subject | Moxifloxacin | Small molecule | 800 mg | — |
Indications
No indication recorded.